Effects of dietary supplementation of probiotic and Spirulina platensis microalgae powder on growth performance immune response, carcass characteristics, gastrointestinal microflora and meat quality in broilers chick.

BACKGROUND: With the potential development of human pathogenic bacteria resistant to antibiotics, the use of antibiotics as growth promoter in poultry production was banned in different countries, and it has forced the poultry industry to consider 'Biologically safer' alternatives to antibiotics, among which the probiotics and microalgae can be mentioned. OBJECTIVE: Present study aimed to compare Spirulina platensis microalgae in combination with a native probiotic as an alternative to antibiotics. METHODS: 336 male broiler chicks were allotted into 7 treatments and 4 repetitions in a completely randomised design to evaluate chick's performance and immune response to different treatment based on indexes as feed intake, weight gain, feed conversion ratio, humoral immunity, carcass characteristics, thigh and breast pH, intestinal morphology and microbial population. European production efficiency coefficient was also reported. RESULTS: No significant difference was appeared in the pH of thigh and breast meat (p > 0.05). Supplementation of diets with SP0.3 revealed better villi height, villi length to crypt depth ratio and villi surface. With significant difference (p < 0.05), the highest and lowest colonies of Lactobacillus and E. coli were recorded for PR0.5 SP0.3 treatments. CONCLUSIONS: Supplementation of broilers diets either with probiotic prepared from the microorganism isolated of native birds (1 g/kg) or S. platensis (0.2 g/kg) alone and their combination (0.3 g/kg of S. platensis in combination with 0.5 g/kg of native probiotic) are promising and can be a good alternative to antibiotics, lead to progress of broiler's performance.

Effects of green tea phytosome on growth performance and intestinal integrity under coccidiosis infection challenge in broilers.

This research examined the effects of feeding phytosomal green tea on broilers infected with coccidia. To provide phytosome, green tea extract was loaded into soy lecithin. Groups of chicks included uninfected and untreated control (NC), infected and untreated control (PC), infected and treated with salinomycin control (SC), infected and treated with 300 and 400 mL of green tea extract (GTE300, GTE400), infected and treated with 200, 300, 400 and 500 mL of green tea phytosome (GTP200, GTP300, GTP400, and GTP500). At 14-days posthatch, chickens were orally gavaged, except the NC group with a coccidia vaccine 30 times larger than the approved dose. Body weight (BW), feed intake (FI), and feed conversion ratio (FCR) were determined at 7, 14, 20, 28, 35, and 42 d. The characteristics of the carcass, internal organs and intestinal morphology were assessed on d 42. Applying overdose of coccidiosis vaccine showed experimental Eimeria infection, led to decrease in FI and BW, and increased FCR compared to PC group (P < 0.001). Meanwhile salinomycin, green tea extract, and green tea phytosome compensated the negative effects of Eimeria infection on growth performance. The treatments did not affect carcass, breast, and thigh relative weights. Interestingly, abdominal fat percent was significantly lower in chickens fed GTP300, GTP400, and GTP500 than in those fed GTE300, GTE300, and GTP200 (P < 0.0001). In comparison to the basal diet plus green tea extract forms and NC groups, the PC group increased the relative weights of the liver, spleen, bursa, and pancreas (P < 0.05). The highest values of villus height and villus height to crypt ratio were obtained in duodenum, jejunum and ileum in GTP300 group (P < 0.0001), while, villi diameter in duodenum and ileum decreased the most in GTP300 and GTP500, respectively (P < 0.0001). Consequently, as natural anticoccidial drug delivery systems, 300 mL of green tea phytosome can be introduced as the optimal dose to maximize the benefits of phytosome for intestinal integrity and reduce the consumption of green tea extract.

In ovo feeding of beta-hydroxy beta-methylbutyrate and dextrin optimized growth performance of broiler for pre-placement holding time using the Box-Behnken response surface design.

To investigate the effect of in ovo feeding (IOF) of beta-hydroxy beta-methylbutyrate (HMB), dextrin and post-hatching water and feed deprivation time on growth performance of broilers, 1,500 eggs were assigned into 15 experimental runs of Box-Behnken design, including three levels IOF of HMB (0%, 0.5% and 1%), dextrin (0%, 20% and 40%) and three levels of the first water and feed deprivation (6, 27 and 48 hr). After hatching, day-old chicks (seven males and seven females) from each replicate were then selected and randomly assigned to 60 floor pens for a 42-day feeding trial. The experimental data were fitted to the quadratic response surface models, and the goodness of fit of the models was expressed by the R2 value. The interaction between IOF of dextrin and timing of first feed deprivation had the largest effect on body weight of chicks at day 7 (BW7) and corrected European production efficiency factor (EPEF). In ovo feeding of dextrin reduced negative effects of delayed access to feed and water after hatch up to 48 hr on BW7, body weight of chicks at day 42, EPEF and corrected EPEF. The results of the current study suggested that the EPEF corrected by hatchability could provide the better understanding of IOF experimental findings. The ridge optimization analysis revealed that the optimal levels of HMB and dextrin inclusion in eggs and timing of first feed deprivation for maximum corrected EPEF were 0.37, 15.94% and 7.22 hr, respectively. These results demonstrate that the Box-Behnken statistical design and response surface models are effective to describe the relationship between IOF of nutrients and pre-placement holding time and predict the performance of broilers to achieve the optimal target.

Manipulation of broiler chickens sex differentiation by in ovo injection of aromatase inhibitors, and garlic and tomato extracts.

The influence of in ovo administration of aromatase inhibitors, clomiphen citrate, tomoxifen, and garlic and tomato extracts on sex differentiation in broiler chickens were investigated in 2 experiments. Five hundred, and 1,000 fertile eggs from Ross 308 strain were used in experiments 1 and 2, respectively. In both experiments, eggs were divided into 5 groups: control group (DW, 0.1 mL/egg), tomoxifen (0.05 mg/egg), clomiphene citrate (0.05 mg/egg), garlic and tomato extracts (0.1 mL/egg). Eggs were sanitized and prepared for incubation in a regular automatic hatchery. Experimental preparations were injected into eggs at day 5 of the incubation period. Injection sites on the eggs were cleaned with 70% ethylic alcohol, bored by a needle, and aromatase inhibitors were injected into the white from the thin end of the eggs by insulin syringe and then sealed by melted paraffin. In experiment 1, hatched one-day-old chicks (mixed-sex) were raised till 42 days of age in 25 floor pens with a completely randomized design. Experiment 2 was designed to investigate the effects of sex and treatments on the feed-to-gain ratio of broiler chicks. In experiment 2, hatched one-day-old chicks were feather sexed and raised till 42 days of age in 50 floor pens. A completely randomized design with a 2 × 5 factorial arrangement of treatments (sex×treatment) was used. Gonads of the chicks were checked to determine their sex on day 42 by optic microscope to make sure feather sexing was correct. At the end of both experiments, on day 42, one bird from each pen was slaughtered for carcass analysis. In experiment 1, hatchability and the one-day-old weight of chicks showed no significant differences among treatments (P > 0.05). However, in ovo administration of garlic and tomato extracts caused the highest percentage of male chicks (P < 0.05). Also, the percentage of thighs and wings of the males were significantly higher than those of females (P < 0.05). In experiment 2, feed-to-gain ratio of male and female broiler chicks showed no significant differences among treatments (P > 0.05).